Paper Details

  1. Home
  2. Paper Details

Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial.

Author: BlindheimA, GjestadR, JoaI, JohnsenE, KrokenR A, LøbergE M, Munk-JørgensenP, ReitanS K, RettenbacherM, StabellL A

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Antipsychotics may improve clinical insight in people with schizophrenia spectrum disorders, but more research is needed, especially in mixed populations of first- and multiepisode patients.
Paper Details　
Original Abstract of the Article :
Antipsychotic treatment may improve clinical insight. However, previous studies have reported inconclusive findings on whether antipsychotics improve insight over and above the reduction in symptoms of psychosis. These studies assessed homogeneous samples in terms of stage of illness. Randomised stu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311854/

データ提供：米国国立医学図書館（NLM）

Clinical Insight in Schizophrenia Spectrum Disorders

Schizophrenia spectrum disorders are complex mental illnesses that can significantly impact an individual's life. This research investigates the impact of antipsychotic treatment on clinical insight, the ability to recognize and understand one's own illness. The study examined the effects of amisulpride, aripiprazole, and olanzapine, three commonly used antipsychotics, on clinical insight in a mixed population of first- and multi-episode schizophrenia spectrum disorders. The researchers aimed to shed light on the potential of antipsychotics to improve insight beyond symptom reduction.

Antipsychotics and Clinical Insight

The study's findings are inconclusive regarding the ability of antipsychotics to improve insight over and above symptom reduction. However, the researchers emphasize the need for further investigation into the relationship between antipsychotic treatment and clinical insight, particularly in a heterogeneous population of patients with schizophrenia spectrum disorders.

A Journey of Understanding

This research is a journey through the complex landscape of schizophrenia spectrum disorders, exploring the relationship between treatment, symptoms, and clinical insight. The study highlights the importance of understanding the individual needs and experiences of patients and finding ways to improve their awareness and understanding of their illness. It's like navigating a vast desert, where the path towards recovery is often unclear and requires careful consideration of various treatment approaches.

Dr.Camel's Conclusion

This research is a reminder that the desert of mental illness is vast and complex. Understanding the interplay between treatment, symptoms, and clinical insight is a critical step in providing effective care for individuals with schizophrenia spectrum disorders. It encourages further research into the role of antipsychotics in promoting insight and empowering patients to take ownership of their recovery.

Date :
  1. Date Completed 2023-07-03
  2. Date Revised 2023-11-16
Further Info :

Pubmed ID

37386462

DOI: Digital Object Identifier

PMC10311854

Related Literature

Article Analysis
・Effective treatment of schizophrenia
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.